Sale!

SCN3A Gene Epilepsy focal SCN3A related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SCN3A gene plays a crucial role in the proper functioning of the brain’s neurons. Mutations in this gene can lead to various neurological disorders, including a specific form of epilepsy known as focal SCN3A-related epilepsy. This condition is characterized by seizures that start in one area of the brain and can spread to other parts, potentially causing a range of symptoms from sensory disturbances to convulsions.

To diagnose this genetic condition accurately, DNA Labs UAE offers a specialized genetic test targeting the SCN3A gene. The test is designed to identify mutations in the SCN3A gene that are linked to the development of focal epilepsy. By analyzing a patient’s DNA, the test can provide crucial information for the diagnosis, treatment planning, and management of the condition.

The cost of the SCN3A gene epilepsy focal SCN3A-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect the presence of SCN3A mutations. Early and accurate diagnosis through this test can significantly impact the management of the condition, allowing for targeted treatment strategies that can improve the quality of life for individuals affected by SCN3A-related epilepsy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN3A Gene Epilepsy focal SCN3A related Genetic Test

Test Name: SCN3A Gene Epilepsy focal SCN3A related Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SCN3A Gene Epilepsy, focal, SCN3A related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN3A Gene Epilepsy, focal, SCN3A related.

Test Details:

The SCN3A gene is associated with a type of epilepsy called focal epilepsy. Focal epilepsy is a type of epilepsy that starts in a specific part of the brain and can cause seizures that affect only one side of the body or one specific area of the body.

A NGS genetic test can be used to analyze the SCN3A gene for mutations or variations that may be associated with focal epilepsy. This test uses next-generation sequencing technology to examine the DNA sequence of the SCN3A gene and identify any genetic changes that may be contributing to the development of epilepsy.

By identifying these genetic changes, doctors and genetic counselors can provide more personalized treatment and management options for individuals with SCN3A-related epilepsy. This may include medications, dietary changes, or other therapies that can help control seizures and improve quality of life.

Test Name SCN3A Gene Epilepsy focal SCN3A related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN3A Gene Epilepsy, focal, SCN3A related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN3A Gene Epilepsy, focal, SCN3A related
Test Details

The SCN3A gene is associated with a type of epilepsy called focal epilepsy. Focal epilepsy is a type of epilepsy that starts in a specific part of the brain and can cause seizures that affect only one side of the body or one specific area of the body.

A NGS genetic test can be used to analyze the SCN3A gene for mutations or variations that may be associated with focal epilepsy. This test uses next-generation sequencing technology to examine the DNA sequence of the SCN3A gene and identify any genetic changes that may be contributing to the development of epilepsy.

By identifying these genetic changes, doctors and genetic counselors can provide more personalized treatment and management options for individuals with SCN3A-related epilepsy. This may include medications, dietary changes, or other therapies that can help control seizures and improve quality of life.